{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:27:53Z","timestamp":1788143273359,"version":"build-2803163510"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":440,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1111\/bjd.12897","type":"journal-article","created":{"date-parts":[[2014,3,5]],"date-time":"2014-03-05T03:52:42Z","timestamp":1393991562000},"page":"90-96","source":"Crossref","is-referenced-by-count":9,"title":["Rapid detection of\n                    <i>HLA-A*31:01<\/i>\n                    allele in DNA and blood samples using loop-mediated isothermal amplification"],"prefix":"10.1093","volume":"171","author":[{"given":"Y.K.","family":"Cheung","sequence":"first","affiliation":[{"name":"Department of Medicine and Therapeutics; The Chinese University of Hong Kong; Prince of Wales Hospital; Hong Kong SAR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kwok","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics; The Chinese University of Hong Kong; Prince of Wales Hospital; Hong Kong SAR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics; The Chinese University of Hong Kong; Prince of Wales Hospital; Hong Kong SAR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Kwan","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics; The Chinese University of Hong Kong; Prince of Wales Hospital; Hong Kong SAR China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,6,18]]},"reference":[{"key":"10.1111\/bjd.12897-BIB0001|bjd12897-cit-0001","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"10.1111\/bjd.12897-BIB0002|bjd12897-cit-0002","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.12897-BIB0003|bjd12897-cit-0003","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/hmg\/ddq537","article-title":"Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population","volume":"20","author":"Ozeki","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1111\/bjd.12897-BIB0004|bjd12897-cit-0004","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.eplepsyres.2011.08.010","article-title":"Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans","volume":"97","author":"Kim","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1111\/bjd.12897-BIB0005|bjd12897-cit-0005","unstructured":"Genin E Chen DP Hung SI et\u00a0al HLA-A*3101 is more strongly associated with carbamazepine-induced drug reaction with eosinophilia and systemic symptoms than with carbamazepine-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis"},{"key":"10.1111\/bjd.12897-BIB0006|bjd12897-cit-0006","doi-asserted-by":"crossref","first-page":"641089","DOI":"10.1155\/2013\/641089","article-title":"Scientific challenges and implementation barriers to translation of pharmacogenomics in clinical practice","volume":"2013","author":"Lam","year":"2013","journal-title":"ISRN Pharmacol"},{"key":"10.1111\/bjd.12897-BIB0007|bjd12897-cit-0007","first-page":"135","article-title":"History of DNA typing for the human MHC","volume":"1","author":"Middleton","year":"1999","journal-title":"Rev Immunogenet"},{"key":"10.1111\/bjd.12897-BIB0008|bjd12897-cit-0008","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1373\/clinchem.2009.127894","article-title":"New testing approach in HLA genotyping helps overcome barriers in effective clinical practice","volume":"55","author":"Cheng","year":"2009","journal-title":"Clin Chem"},{"key":"10.1111\/bjd.12897-BIB0009|bjd12897-cit-0009","doi-asserted-by":"crossref","first-page":"E63","DOI":"10.1093\/nar\/28.12.e63","article-title":"Loop-mediated isothermal amplification of DNA","volume":"28","author":"Notomi","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1111\/bjd.12897-BIB0010|bjd12897-cit-0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/MB:14:1:01","article-title":"Restriction primers as short as 6-mers for PCR amplification of bacterial and plant genomic DNA and plant viral RNA","volume":"14","author":"Ryu","year":"2000","journal-title":"Mol Biotechnol"},{"key":"10.1111\/bjd.12897-BIB0011|bjd12897-cit-0011","doi-asserted-by":"crossref","first-page":"D913","DOI":"10.1093\/nar\/gkq1128","article-title":"Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations","volume":"39","author":"Gonzalez-Galarza","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1111\/bjd.12897-BIB0012|bjd12897-cit-0012","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jclinepi.2004.12.009","article-title":"Sample size calculation should be performed for design accuracy in diagnostic test studies","volume":"58","author":"Flahault","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/bjd.12897-BIB0013|bjd12897-cit-0013","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-0039.2011.01731.x","article-title":"Characterization of 236 novel alleles at the HLA-A, -B, -C, -DRB1, -DQB1 and -DPB1 loci from China Marrow Donor Program","volume":"78","author":"Li","year":"2011","journal-title":"Tissue Antigens"},{"key":"10.1111\/bjd.12897-BIB0014|bjd12897-cit-0014","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.0001-2815.2004.00234.x","article-title":"HLA class I allele distribution of a Hong Kong Chinese population based on high-resolution PCR-SSOP typing","volume":"63","author":"Middleton","year":"2004","journal-title":"Tissue Antigens"},{"key":"10.1111\/bjd.12897-BIB0015|bjd12897-cit-0015","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1111\/bjd.12897-BIB0016|bjd12897-cit-0016","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","article-title":"Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese","volume":"48","author":"Man","year":"2007","journal-title":"Epilepsia"},{"key":"10.1111\/bjd.12897-BIB0017|bjd12897-cit-0017","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","article-title":"Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population","volume":"49","author":"Locharernkul","year":"2008","journal-title":"Epilepsia"},{"key":"10.1111\/bjd.12897-BIB0018|bjd12897-cit-0018","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4103\/0378-6323.57718","article-title":"Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians","volume":"75","author":"Mehta","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/bjd.12897-BIB0019|bjd12897-cit-0019","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1528-1167.2010.02533.x","article-title":"Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population","volume":"51","author":"Tassaneeyakul","year":"2010","journal-title":"Epilepsia"},{"key":"10.1111\/bjd.12897-BIB0020|bjd12897-cit-0020","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.yebeh.2010.08.007","article-title":"Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China","volume":"19","author":"Wu","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1111\/bjd.12897-BIB0021|bjd12897-cit-0021","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-4632.2010.04745.x","article-title":"Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population","volume":"50","author":"Chang","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12897-BIB0022|bjd12897-cit-0022","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.seizure.2011.02.003","article-title":"Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland","volume":"20","author":"Wang","year":"2011","journal-title":"Seizure"},{"key":"10.1111\/bjd.12897-BIB0023|bjd12897-cit-0023","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00228-011-1009-4","article-title":"Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients","volume":"67","author":"Zhang","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/bjd.12897-BIB0024|bjd12897-cit-0024","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/epi.12217","article-title":"HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese","volume":"54","author":"Cheung","year":"2013","journal-title":"Epilepsia"},{"key":"10.1111\/bjd.12897-BIB0025|bjd12897-cit-0025","unstructured":"Food and Drug Administration Information for Healthcare Professionals: Dangerous or Even Fatal Skin Reactions - Carbamazepine (marketed as Carbatrol, Equetro, Tegretol, and generics), 12 December 2007 http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketdrugsafetyinformationforPatientsandProviders\/ucm124718.htm"},{"key":"10.1111\/bjd.12897-BIB0026|bjd12897-cit-0026","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/clpt.2013.55","article-title":"HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children","volume":"94","author":"Amstutz","year":"2013","journal-title":"Clin Pharmacol Ther"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12897","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12897\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:08:52Z","timestamp":1676365732000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/171\/1\/90\/6615685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,18]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.12897","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6,18]]}}}